Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence

Nature Neuroscience

Volumn 14, Issue 4, 2011, Pages 417-419

  Counotte, Danielle S ^a   Goriounova, Natalia A L ^a   Li, Ka Wan ^a   Loos, Maarten ^a   Van Der Schors, Roel C ^a   Schetters, Dustin ^b   Schoffelmeer, Anton N M ^b   Smit, August B ^a   Mansvelder, Huibert D ^a   Pattij, Tommy ^b   Spijker, Sabine ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR AGONIST; NICOTINE;

ADOLESCENCE; ANIMAL CELL; ARTICLE; ATTENTION DEFICIT DISORDER; DOWN REGULATION; DRUG EXPOSURE; IN VIVO STUDY; NERVE ENDING; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SYNAPSE;

ADOLESCENT; AGE FACTORS; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; RATS; SYNAPTIC TRANSMISSION; TOBACCO USE DISORDER;

EID: 79953215206     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn.2770     Document Type: Article

References (15)

1. Casey, B.J., Tottenham, N., Liston, C. & Durston, S. Trends Cogn. Sci. 9, 104-110 (2005)
2. Chassin, L., Presson, C.C., Rose, J.S. & Sherman, S.J. Health Psychol. 15, 478-484 (1996)
3. Slotkin, T.A. Toxicol. Appl. Pharmacol. 198, 132-151 (2004)
4. Jacobsen, L.K. et al. Biol. Psychiatry 57, 56-66 (2005)
5. Jacobsen, L.K., Slotkin, T.A., Mencl, W.E., Frost, S.J. & Pugh, K.R. Neuropsychopharmacology 32, 2453-2464 (2007)
6. Mathers, M., Toumbourou, J.W., Catalano, R.F., Williams, J. & Patton, G.C. Addiction 101, 948-958 (2006)
7. WHO-Europe. Health policy for children and adolescents. (No. 4) (eds. C. Currie, et al.) (Copenhagen, 2004)
8. Spear, L.P. Neurosci. Biobehav. Rev. 24, 417-463 (2000)
9. Counotte, D.S. et al. Neuropsychopharmacology 34, 299-306 (2009)
10. Pattij, T. & Vanderschuren, L.J. Trends Pharmacol. Sci. 29, 192-199 (2008)
11. Robbins, T.W. Psychopharmacology (Berl.) 163, 362-380 (2002)
12. Dalley, J.W., Cardinal, R.N. & Robbins, T.W. Neurosci. Biobehav. Rev. 28, 771-784 (2004)
13. Mateo, Z. & Porter, J.T. Neuroscience 146, 1062-1072 (2007)
14. Chudasama, Y. et al. Behav. Brain Res. 146, 105-119 (2003)
15. Zucker, R.S. Annu. Rev. Neurosci. 12, 13-31 (1989).